Takara Bio Inc. (FRA:TF2)

Takara Bio Statistics

Total Valuation

Takara Bio has a market cap or net worth of EUR 553.94 million. The enterprise value is 494.17 million.

Market Cap	553.94M
Enterprise Value	494.17M

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	120.42M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	9.27%
Float	44.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.18
PB Ratio	0.94
P/TBV Ratio	1.23
P/FCF Ratio	n/a
P/OCF Ratio	34.49
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.19, with an EV/FCF ratio of -4.68.

EV / Earnings	-13.44
EV / Sales	2.02
EV / EBITDA	20.19
EV / EBIT	n/a
EV / FCF	-4.68

Financial Position

The company has a current ratio of 5.50, with a Debt / Equity ratio of 0.10.

Current Ratio	5.50
Quick Ratio	3.73
Debt / Equity	0.10
Debt / EBITDA	2.27
Debt / FCF	-0.55
Interest Coverage	-1.96

Financial Efficiency

Return on equity (ROE) is -5.79% and return on invested capital (ROIC) is -0.27%.

Return on Equity (ROE)	-5.79%
Return on Assets (ROA)	-0.24%
Return on Invested Capital (ROIC)	-0.27%
Return on Capital Employed (ROCE)	-0.40%
Revenue Per Employee	142,685
Profits Per Employee	-20,664
Employee Count	1,779
Asset Turnover	0.34
Inventory Turnover	1.58

Taxes

In the past 12 months, Takara Bio has paid 9.10 million in taxes.

Income Tax	9.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.29%
50-Day Moving Average	4.94
200-Day Moving Average	4.80
Relative Strength Index (RSI)	32.75
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Takara Bio had revenue of EUR 253.84 million and -36.76 million in losses. Loss per share was -0.31.

Revenue	253.84M
Gross Profit	139.29M
Operating Income	-2.86M
Pretax Income	-27.39M
Net Income	-36.76M
EBITDA	25.40M
EBIT	-2.86M
Loss Per Share	-0.31

Balance Sheet

The company has 121.18 million in cash and 57.59 million in debt, giving a net cash position of 63.59 million.

Cash & Cash Equivalents	121.18M
Total Debt	57.59M
Net Cash	63.59M
Net Cash Per Share	n/a
Equity (Book Value)	591.17M
Book Value Per Share	4.90
Working Capital	207.27M

Cash Flow

In the last 12 months, operating cash flow was 16.06 million and capital expenditures -121.72 million, giving a free cash flow of -105.65 million.

Operating Cash Flow	16.06M
Capital Expenditures	-121.72M
Free Cash Flow	-105.65M
FCF Per Share	n/a

Margins

Gross margin is 54.87%, with operating and profit margins of -1.13% and -14.48%.

Gross Margin	54.87%
Operating Margin	-1.13%
Pretax Margin	-10.79%
Profit Margin	-14.48%
EBITDA Margin	10.01%
EBIT Margin	-1.13%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 2.45%.

Dividend Per Share	0.10
Dividend Yield	2.45%
Dividend Growth (YoY)	0.51%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	2.45%
Earnings Yield	-6.64%
FCF Yield	-19.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 29, 2011. It was a forward split with a ratio of 400.

Last Split Date	Mar 29, 2011
Split Type	Forward
Split Ratio	400

Scores

Takara Bio has an Altman Z-Score of 3.37 and a Piotroski F-Score of 2.

Altman Z-Score	3.37
Piotroski F-Score	2